17-2337704-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_014853.3(SGSM2):c.16G>A(p.Asp6Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000132 in 151,684 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_014853.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SGSM2 | NM_014853.3 | c.16G>A | p.Asp6Asn | missense_variant | 1/24 | ENST00000268989.8 | NP_055668.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SGSM2 | ENST00000268989.8 | c.16G>A | p.Asp6Asn | missense_variant | 1/24 | 1 | NM_014853.3 | ENSP00000268989 | P4 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151684Hom.: 0 Cov.: 32
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.00000144 AC: 2AN: 1385062Hom.: 0 Cov.: 30 AF XY: 0.00000145 AC XY: 1AN XY: 687436
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151684Hom.: 0 Cov.: 32 AF XY: 0.0000270 AC XY: 2AN XY: 74118
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 26, 2022 | The c.16G>A (p.D6N) alteration is located in exon 1 (coding exon 1) of the SGSM2 gene. This alteration results from a G to A substitution at nucleotide position 16, causing the aspartic acid (D) at amino acid position 6 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at